With regard to all federal funding provided to MySafe Society since January 2020: (a) what are the details of each contribution, grant and contract, including the (i) department or agency providing the funding, (ii) total value, (iii) start and end dates, (iv) purpose of the funding; (b) for each expenditure in (a), did the agreement require MySafe Society to report to the government on (i) participant health outcomes, (ii) overdose events, (iii) diversion of dispensed substances to unregistered individuals; (c) what reporting, if any, was received by the government under the requirements in (b); (d) was any audit or evaluation of the agreements in (a) conducted, and, if so, what were the findings; (e) what are the details of any federal funding specifically used for the acquisition, installation or operation of drug-dispensing machines, including the (i) number of machines funded, (ii) locations where machines were installed, (iii) total federal contribution toward the machines; and (f) at the time each funding agreement was signed, was the federal government aware that MySafe Society would be using federal funds to dispense opioids through machines, and, if so, (i) which department or official approved the funding with that knowledge, (ii) what controlled substances were known to be dispensed, (iii) what safeguards, if any, were required as a condition of funding?